Repros Therapeutics Inc (NASDAQ: RPRX) share are trading higher by $1.05 at $1.87 or 125 percent in Wednesday's session. The catalyst for the rally is a positive report on Proellex, which helps control menstrual bleeding in women with uterine fibroids. The drug reached its primary endpoint and showed reduction in fibroid size.
After a higher open, it retreated and found support ahead of the top of Tuesday's range ($0.86), only reaching $0.97 before resuming its move higher. So far, it has crossed the $2 barrier reaching $2.03 and has backed off.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
That marks the first time over $2 since December, when it peaked at $2.34.
It should be noted the rally is taking place on much higher than average volume. With less than two hours remaining, over 20 million shares have traded compared to its nine-day average of 885,000.